Phytochemicals: A Multitargeted Approach to Gynecologic Cancer Therapy

por Farrand, Lee, Oh, Se-Woong, Song, Yong Sang, Tsang, Benjamin K.
Publicado 2014

An Improved Quantitative Approach for the Assessment of Mitochondrial Fragmentation in Chemoresistant Ovarian Cancer Cells

por Farrand, Lee, Kim, Ji Young, Im-Aram, Akechai, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K.
Publicado 2013

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum

por Ali, Ahmed Y, Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K
Publicado 2012

The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer Cells

por Im-aram, Akechai, Farrand, Lee, Bae, Seung-Min, Song, Gwonhwa, Song, Yong Sang, Han, Jae Yong, Tsang, Benjamin K.
Publicado 2013

The Diarylheptanoid Hirsutenone Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin via Modulation of Apoptosis-inducing Factor and X-linked Inhibitor of Apoptosis

por Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Im-aram, Akechai, Lee, Jihoon, Suh, Jeong-Yong, Lee, Ki-Won, Lee, Hyong Joo, Tsang, Benjamin K.
Publicado 2014

β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features

por Park, Soeun, Park, Jung Min, Park, Minsu, Ko, Dongmi, Kim, Seongjae, Seo, Juyeon, Nam, Kee Dal, Jung, Eunsun, Farrand, Lee, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong
Publicado 2022

A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer

por Park, Jung Min, Kim, Yoon-Jae, Park, Soeun, Park, Minsu, Farrand, Lee, Nguyen, Cong-Truong, Ann, Jihyae, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Kim, Ji Young, Seo, Jae Hong
Publicado 2020

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells

por Park, Soeun, Kim, Yoon-Jae, Park, Jung Min, Park, Minsu, Nam, Kee Dal, Farrand, Lee, Nguyen, Cong-Truong, La, Minh Thanh, Ann, Jihyae, Lee, Jeewoo, Kim, Ji Young, Seo, Jae Hong
Publicado 2021

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase

por Seo, Juyeon, Park, Minsu, Ko, Dongmi, Kim, Seongjae, Park, Jung Min, Park, Soeun, Nam, Kee Dal, Farrand, Lee, Yang, Jinsol, Seok, Chaok, Jung, Eunsun, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong
Publicado 2023

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR

por Kim, Seongjae, Park, Jung Min, Park, Soeun, Jung, Eunsun, Ko, Dongmi, Park, Minsu, Seo, Juyeon, Nam, Kee Dal, Kang, Yong Koo, Lee, Kyoungmin, Farrand, Lee, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong
Publicado 2023

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response

por Kim, Ji Young, Cho, Tae-Min, Park, Jung Min, Park, Soeun, Park, Minsu, Nam, Kee Dal, Ko, Dongmi, Seo, Juyeon, Kim, Seongjae, Jung, Eunsun, Farrand, Lee, Nguyen, Cong-Truong, Hoang, Van-Hai, Thanh La, Minh, Ann, Jihyae, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Kim, Yoon-Jae, Seo, Jae Hong
Publicado 2022